{"gao_id": "GAO-24-107305", "published": "2024-06-25T12:00:00Z", "released": "2024-06-25T08:00:00Z", "summary": "The Food and Drug Administration helps ensure the safety of human medical products and more than 80% of the U.S. food supply, among other things. The Food and Drug Omnibus Reform Act of 2022 includes a provision that we assess how an office within FDA handles correspondence for FDA's Commissioner. The office receives letters and emails that its staff must determine where to route. Correspondence...", "title": "Food and Drug Administration: Office of the Executive Secretariat's Processes for Correspondence Were Consistent with Selected Internal Control Standards", "topics": ["Government Operations", "Policies and procedures", "Internal controls", "Food", "Social media", "Common carrier", "Whistleblowers", "Precious metals", "Health care", "Food standards", "Consumer complaints"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-24-107305", "versions": [{"title": "Full Report (9 pages)", "url": "https://www.gao.gov/assets/gao-24-107305.pdf"}]}